Cargando…

Spleen participation in partial MHC class II construct neuroprotection in stroke

Pathological progression of stroke in the peripheral and central nervous systems (PNS and CNS) is characterized by multiple converging signalling pathways that exacerbate neuroinflammation‐mediated secondary cell death. This creates a need for a novel type of immunotherapy capable of simultaneously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, John, Kingsbury, Chase, Lee, Jea‐Young, Vandenbark, Arthur A., Meza‐Romero, Roberto, Offner, Halina, Borlongan, Cesar V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298973/ https://www.ncbi.nlm.nih.gov/pubmed/32237074 http://dx.doi.org/10.1111/cns.13369

Ejemplares similares

Sex-dependent treatment of chronic EAE with partial MHC class II constructs
por: Benedek, Gil, et al.
Publicado: (2017)

Major histocompatibility complex Class II-based therapy for stroke
por: Gonzales-Portillo, Bella M., et al.
Publicado: (2021)

Surviving the storm: Dealing with COVID-19
por: Vandenbark, Arthur A., et al.
Publicado: (2020)

HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection
por: Benedek, Gil, et al.
Publicado: (2015)

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
por: Vandenbark, Arthur A., et al.
Publicado: (2019)

Partial MHC/Neuroantigen Peptide Constructs: A Potential Neuroimmune-Based Treatment for Methamphetamine Addiction
por: Loftis, Jennifer M., et al.
Publicado: (2013)

Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease
por: Matejuk, Agata, et al.
Publicado: (2021)

Neuroprotective effects of human bone marrow mesenchymal stem cells against cerebral ischemia are mediated in part by an anti-apoptotic mechanism
por: Zhang, Yuyang, et al.
Publicado: (2019)

Stroke gets in your eyes: stroke-induced retinal ischemia and the potential of stem cell therapy
por: Kingsbury, Chase, et al.
Publicado: (2019)

Microglia and astrocyte involvement in neurodegeneration and brain cancer
por: Vandenbark, Arthur A., et al.
Publicado: (2021)

Novel therapeutic for multiple sclerosis protects white matter function in EAE mouse model
por: Zerimech, Sarah, et al.
Publicado: (2023)

PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1
por: Bodhankar, Sheetal, et al.
Publicado: (2013)

Estrogen-induced compensatory mechanisms protect IL-10-deficient mice from developing EAE
por: Seifert, Hilary A., et al.
Publicado: (2019)

Fast-tracking regenerative medicine for traumatic brain injury
por: Bonsack, Brooke, et al.
Publicado: (2020)

Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke
por: Bodhankar, Sheetal, et al.
Publicado: (2014)

RTL551 Treatment of EAE Reduces CD226 and T-bet+ CD4 T Cells in Periphery and Prevents Infiltration of T-bet+ IL-17, IFN-γ Producing T Cells into CNS
por: Sinha, Sushmita, et al.
Publicado: (2011)

Eyeballing stroke: Blood flow alterations in the eye and visual impairments following transient middle cerebral artery occlusion in adult rats
por: Lee, Jea-young, et al.
Publicado: (2020)

Single Chain Recombinant HLA-DQ2.5/peptide Molecules Block α2-gliadin-Specific Pathogenic CD4(+) T Cell Proliferation and Attenuate Production of Inflammatory Cytokines: A Potential Therapy for Celiac Disease
por: Huan, J, et al.
Publicado: (2010)

Characterization of human platelet binding of recombinant T cell receptor ligand
por: Itakura, Asako, et al.
Publicado: (2010)

The partial dissociation of MHC class I–bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1
por: Papakyriakou, Athanasios, et al.
Publicado: (2018)

IL-2/IL-2R Antibody Complex Enhances Treg-Induced Neuroprotection by Dampening TNF-α Inflammation in an In Vitro Stroke Model
por: Borlongan, Mia C., et al.
Publicado: (2021)

Probing Gut Participation in Parkinson’s Disease Pathology and Treatment via Stem Cell Therapy
por: Lee, Jea-Young, et al.
Publicado: (2023)

Novel Humanized Recombinant T Cell Receptor Ligands Protect the Female Brain After Experimental Stroke
por: Pan, Jie, et al.
Publicado: (2014)

Stem cell secretome derived from human amniotic fluid affords neuroprotection in an ischemic model
por: Kingsbury, Chase, et al.
Publicado: (2021)

Melatonin-Based Therapeutics for Neuroprotection in Stroke
por: Shinozuka, Kazutaka, et al.
Publicado: (2013)

MHC class I multimers
por: Sun, Mei-Yi, et al.
Publicado: (2001)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Human stem cells transplanted into the rat stroke brain migrate to the spleen via lymphatic and inflammation pathways
por: Xu, Kaya, et al.
Publicado: (2019)

Ligation of MHC Class II Induces PKC-Dependent Clathrin-Mediated Endocytosis of MHC Class II
por: Masaki, Kento, et al.
Publicado: (2020)

Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1(G93A) mice
por: Tomiyama, Ana Laura M. R., et al.
Publicado: (2023)

Structures of peptide-free and partially loaded MHC class I molecules reveal mechanisms of peptide selection
por: Anjanappa, Raghavendra, et al.
Publicado: (2020)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Organizing MHC Class II Presentation
por: Fooksman, David R.
Publicado: (2014)

MHC Class II Presentation in Autoimmunity
por: Ishina, Irina A., et al.
Publicado: (2023)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Stem Cell Transplantation for Neuroprotection in Stroke
por: Shinozuka, Kazutaka, et al.
Publicado: (2013)

Natural Host Genetic Resistance to Lentiviral CNS Disease: A Neuroprotective MHC Class I Allele in SIV-Infected Macaques
por: Mankowski, Joseph L., et al.
Publicado: (2008)

Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta
Publicado: (1990)

Transcriptome analysis of Brucella abortus S19∆per immunized mouse spleen revealed activation of MHC-I and MHC-II pathways
por: Solanki, Khushal Singh, et al.
Publicado: (2019)

Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_ta27j7vnmmetra5d6kq1lf0ubs